1. 44PCorrelation between an automated functional assay that predicts targeted agent (TA) sensitivity and the tumor response of the sorafenib treatment evaluated within the MOST clinical trial. (16th September 2018) Authors: Tredan, O; Zelichov, O; Barbash, Z; Daitsh, Y; Birnbaum, L; Tarcic, G; You, B; Cassier, P; de la Fouchardiere, C; Ray-Coquard, I L; Brahmi, M; Wang, Q; Attignon, V; Baudet, C; Fournier Garin, G; Agrapart, V; Dargenio, A; Chabaud, S; Perol, D; Blay, J-Y Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1435PBevacizumab as first-line treatment in advanced non-squamous non-small cell lung cancer (NSCLC) in patients aged over 65 years in France: Final results of the AVANTAGE study. (23rd October 2018) Authors: Lionel, F; Perol, D; Souquet, P-J; Le Caer, H; Dansin, E; Audigier Valette, C; Mouysset, J-L; Uffredi, M L; Ionescu-Goga, M; Veerabudun, K; Lelarge, Y; Fabre-Guillevin, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 110TiPA phase I dose escalation trial evaluating the impact of an in situ immunization strategy with intra-tumoral injections of Pexa-Vec in combination with ipilimumab in advanced solid tumors with injectable lesions. (17th December 2018) Authors: Marabelle, A; Eberst, L; Terret, C; Pilleul, F; Mastier, C; Bouhamama, A; Gilles-Afchain, L; Laurent, S; Delzano, I; Reynaud, C; Caux, C; Caux, C; Garin, G; Bidaux, A-S; Perol, D; Stojkowitz, N; Homerin, M; Leenders, H; Cassier, P Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 870PDEfficacy and safety of axitinib in metastatic papillary renal carcinoma (mPRC): Results of a GETUG multicenter phase II trial (Axipap). (23rd October 2018) Authors: Negrier, S; Rioux-Leclercq, N; Ravaud, A; Gravis, G; Geoffrois, L; Chevreau, C M; Rolland, F; Blanc, E; Segura-Ferlay, C; Perol, D; Gross Goupil, M; Dermeche, S; Flechon, A; Albiges, L; Escudier, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1345PData-mining of 110 172 electronic patient records with the ConSoRe tool: An analysis of second primary cancer in a comprehensive cancer center. (23rd October 2018) Authors: Heudel, P; Durand, T; Fervers, B; Gomez, F; Rivoire, M; Bachelot, T; Claude, L; Chassagne-Clement, C; Pilleul, F; Mognetti, T; Devaux, Y; Soubirou, J-L; Lasset, C; Perol, D; Chvetzoff, G; Pezet, C; Beaupere, S; Zrounba, P; Blay, J-Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. LBA10Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev. (24th November 2019) Authors: Fujiwara, K; Harter, P; Leary, A; Perol, D; Pignata, S; González-Martín, A; Petru, E; van Nieuwenhuysen, E; Colombo, N; Mäenpää, J; Selle, F; de Gregorio, N; Lorusso, D; Guerra Alia, E M; Lefeuvre-Plesse, C; Buderath, P; Lortholary, A; Burges, A; Pujade-Lauraine, E; Ray-Coquard, I L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P14.127 From next generation sequencing and comparative genomic hybridization to personalised medicine for adult primary brain tumors: the profiler trial. (6th September 2019) Authors: Bonneville-levard, A; Frappaz, D; Pissaloux, D; Wang, Q; Perol, D; Blay, J; Meyronet, D Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗